Rock Creek Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Rock Creek Group's GILD Position: Q4 2023 in Review
Rock Creek Group sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 265 shares — an estimated $19.9K sold.
Rock Creek Group first reported a position in GILD in Q3 2018 and held it in 17 quarters. The position peaked at $1.26M in Q1 2020. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Rock Creek Group reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- Rock Creek Group sold 265 Gilead Sciences shares in Q4 2023, an estimated $19.9K.
- Rock Creek Group first reported a position in Gilead Sciences in Q3 2018 and held it in 17 quarters.
- Rock Creek Group's Gilead Sciences position peaked at $1.26M in Q1 2020.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Rock Creek Group's 13F filing for Q4 2023, filed 13 Feb 2024.